Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan

Butt, Zahid A; Wilkins, Melinda J.; Hamilton, Elizabeth; Todem, David; Gardiner, Joseph C.; Saeed, Mahdi

doi:10.1017/s0950268813000538

Cited by 7 publications

(6 citation statements)

References 19 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overall, our findings are consistent with other analyses of HIV co-infection using state and local surveillance data. In Michigan, 1·8% of HIV-infected individuals were co-infected with HBV [17]. HIV/HCV infection estimates range from 2·2% to 23·6% from public health surveillance database matches in Colorado, Connecticut, Oregon, and Michigan [16, 17].…”

Section: Discussionmentioning

confidence: 99%

“…In Michigan, 1·8% of HIV-infected individuals were co-infected with HBV [17]. HIV/HCV infection estimates range from 2·2% to 23·6% from public health surveillance database matches in Colorado, Connecticut, Oregon, and Michigan [16, 17]. The co-infected proportions we found are lower than estimates from multicenter clinical cohorts, which have reported HBV prevalences of 9–11% among PLWHA in the USA and Europe [7, 12] and HCV prevalences of 20–37% among PLWHA in the USA [10, 11].…”

Section: Discussionmentioning

confidence: 99%

“…Multiple clinical cohort and cross-sectional studies have studied the prevalence of and risk factors for HBV and HCV co-infection in groups of people living with HIV/AIDS (PLWHA) throughout the world [7,[10][11][12][13][14]. Another important method for assessing the prevalence of HIV co-infection with HBV and/or HCV and the characteristics of co-infected patients is to match surveillance data for each infection collected by state or local health departments [15][16][17][18]. Surveillance data are derived from large, geographically well-defined populations and include all positive tests reported to health departments; therefore, such data are more representative than data from highly specialized clinical studies, which are limited to patients selected for enrolment.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

et al. 2014

View full text Add to dashboard Cite

Using surveillance data, we describe the prevalence and characteristics of individuals in New York City (NYC) co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and/or hepatitis C virus (HCV). Surveillance databases including persons reported to the NYC Department of Health and Mental Hygiene with HIV, HBV, and HCV by 31 December 2010 and not known to be dead as of 1 January 2000, were matched with 2000-2011 vital statistics mortality data. Of 140 606 persons reported with HIV, 4% were co-infected with HBV only, 15% were co-infected with HCV only, and 1% were co-infected with HBV and HCV. In all groups, 70-80% were male. The most common race/ethnicity and HIV transmission risk groups were non-Hispanic blacks and men who have sex with men (MSM) for HIV/HBV infection, and non-Hispanic blacks, Hispanics, and injection drug users for HIV/HCV and HIV/HBV/HCV infections. The overall age-adjusted 2000-2011 mortality was higher in co-infected than HIV mono-infected individuals. Use of population-based surveillance data provided a comprehensive characterization of HIV co-infection with HBV and HCV. Our findings emphasize the importance of targeting HIV and viral hepatitis testing and prevention efforts to populations at risk for co-infection, and of integrating HIV and viral hepatitis care and testing services.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

et al. 2014

View full text Add to dashboard Cite

show abstract

“…A retrospective cohort design was utilized in which HIV/AIDS-infected individuals of all age groups residing in Michigan during the period 1 January 2006 to 31 December 2009 were matched to hepatitis B and hepatitis C cases from the same period [28]. The HIV/AIDS data were obtained from the enhanced HIV/AIDS Reporting System (eHARS) maintained by the HIV/STD/VH/TB Epidemiology Section whereas the hepatitis B and C data were obtained from the Michigan Disease Surveillance System maintained by the Surveillance and Infectious Disease Epidemiology Section of MDCH [28]. These datasets were linked together to enable matching of hepatitis B and C and HIV/AIDS cases to the same individual.…”

Section: Methodsmentioning

confidence: 99%

Survival of HIV-positive individuals with hepatitis B and C infection in Michigan

et al. 2013

Self Cite

View full text Add to dashboard Cite

We sought to estimate mortality and associated factors in HIV-hepatitis co-infected individuals in Michigan using a retrospective cohort study. For the study period of 1 January 2006 to 31 December 2009, all HIV-infected individuals were matched to hepatitis B and C cases. In the final Cox proportional hazards regression model, individuals of other [hazard ratio (HR) 2·2, 95% confidence interval (CI) 1·4-3·2] and black (HR 1·3, 95% CI 1·1-1·6) race had decreased survival compared to white race. Similarly, injecting drug users (IDUs) (HR 2·1, 95% CI 1·6-2·6), men who have sex with men (MSM)/IDUs (HR 1·5, 95% CI 1·1-2·2), individuals with undetermined risk (HR 1·5, 95% CI 1·2-1·9) and heterosexual practices (HR 1·4, 95% CI 1·1-1·8) had decreased survival compared to MSM. Additionally, an interaction was found between current HIV status and co-infection. Mortality in HIV-hepatitis co-infected individuals remains a continuing problem. Our study can help in planning interventions to reduce mortality in HIV-infected individuals.

show abstract

“…The exclusion criteria were patient without an incomplete medical record. From this 1333 cases, we excluded 39 cases perinatal transmission, removed 14 duplicate cases and removed another 6 outlier cases with the remaining 1274 HIV patients left ( Figure 1 The sample size was calculated using a single population proportion formula using 4.1% for HBV-HIV prevalence [26] and 6.6% for HCV-HIV prevalence [25] . Using 95% con dence interval and 5% precision with attrition rate of 20%, a minimum of at least 70 participants with HBV-HIV Co-infection and 107 minimum participants for HCV-HIV Co-infection were required.…”

mentioning

confidence: 99%

Viral Hepatitis-HIV Co-Infection and their associated factors in Negeri Sembilan - a cross sectional study from HIV Case Registry

Abas¹,

Jamil²,

Saman³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Viral Hepatitis HIV Co-infection is an important and preventable cause of chronic liver disease, and having them lead to many consequences, especially for those living in wrenched conditions. Thus it is a significant health issue in the communities. This study aimed to determine the prevalence of Viral Hepatitis-HIV Co-Infection and determine the associated variables with this Co-Infection. Methods: A cross-sectional study was done using HIV Case Registry ( Anti Retroviral -(ARV) line listing). We included 1274 patients who were seen under the HIV Clinic services, which were screened for Hepatitis B Virus (HBV) and Hepatitis C Virus ( HCV) upon registered to the clinic. Factors associated with the HBV-HIV and HCV-HIV were determined using bivariate, and multivariate logistic regression analysis using SPSS and odds ratio was used as the measures of association. A P-value of less than 0.05 was considered statistically significant for all the tests. Results: From the 1274 number of HIV patients, the prevalence of HBV-HIV is 5.6% (71 cases), while the prevalence with HCV co-infection was 14.8% (189 cases). As for the frequency of multiple HIV-Coinfection, out of 238 HIV cases with Co-Infection, the majority of 167 cases (70.17%) were HCV-HIV Co-Infected followed by 49 cases (20.5%) were HBV-HIV Co-Infected. In comparison, another 22 cases ( 9.24%) were Co-Infected with HBV-HCV-HIV. In the final model of HBV-HIV Co-Infection, only male gender, CD4 count category less than 199 cells/mm3 and primary care type of facilities were associated with the disease whereas, in the HCV-HIV Coinfection, only male gender, Malay race, Intravenous Drug User (IVDU) modes of transmission, and source of the case from high-risk screening program were associated with the disease. Conclusions: Co-Infection with HCV-HIV is more prevalent from HBV-HIV in our study population. A more targeted intervention of HBV revaccination and more frequent screening of HCV post HCV treatment as reinfection is anticipated in high-risk behaviour patient are some of the intervention programs that can be suggested.

show abstract

Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan

Cited by 7 publications

References 19 publications

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

Survival of HIV-positive individuals with hepatitis B and C infection in Michigan

Viral Hepatitis-HIV Co-Infection and their associated factors in Negeri Sembilan - a cross sectional study from HIV Case Registry

Contact Info

Product

Resources

About